CANF Can-Fite BioPharma Ltd.
Price Chart
Executive Summary
Can-Fite BioPharma has two shelf registration statements (File Nos. 333-269485 and 333-288890) that became effective on March 31, 2026, allowing the company to issue unspecified amounts of securities from time to time. This creates a potential for future dilution, though no specific offering size or timing is disclosed.
Actionable Insight
Monitor for future 424B prospectus supplements or 8-Ks that may announce actual offerings under these shelf registrations, which could lead to near-term dilution given the company's small $7M market cap.
Key Facts
- Two EFFECT filings (Accession Nos. 9999999995-26-001005 and 9999999995-26-001009) from Can-Fite BioPharma became effective on March 31, 2026.
- Each relates to a separate shelf registration statement (333-269485 and 333-288890) under the Securities Act of 1933.
- The filings do not disclose the amount or type of securities to be offered, nor any pricing or timing details.
- Shelf registrations allow companies to issue securities quickly when market conditions are favorable.
Financial Impact
Potential for future dilution; exact magnitude unknown as no offering size is specified.
Risk Factors
- Future issuance under the shelf could significantly dilute existing shareholders.
- Low market cap increases sensitivity to any new share issuance.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (CANF) — Batch item 1 | 9999999995-26-001005 |
| Document: 9999999995-26-001005-index.html | 9999999995-26-001009 |
| Document: 9999999995-26-001005.txt | 9999999995-26-001005 |
| EFFECT Filing (CANF) — Batch item 4 | 9999999995-26-001009 |
| Document: 9999999995-26-001009-index.html | 9999999995-26-001005 |
| Document: 9999999995-26-001009.txt | 9999999995-26-001005 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
5d ago
|
6-K
| $3.20 awaiting T+1 | awaiting T+1 | — | $2.91 (−9.06%) |
|
Jun 2, 2026
7d ago
|
6-K
| $3.11 $3.11 | · 0.00% | ▲ +0.69% | $2.91 (−6.43%) |
|
May 28, 2026
12d ago
|
6-K
| $3.35 $3.24 | ▼ −3.28% | ▼ −3.54% | $2.91 (−13.13%) |
|
May 13, 2026
27d ago
|
6-K
| $3.64 $3.49 | ▼ −4.12% | ▼ −4.90% | $2.91 (−20.05%) |
|
Apr 30, 2026
5w ago
|
6-K
| $3.19 $2.93 | ▼ −8.15% | ▼ −8.37% | $2.91 (−8.78%) |
|
Apr 23, 2026
6w ago
|
6-K
| $2.91 $2.92 | ▲ +0.34% | ▲ +0.18% | $2.91 (+0.00%) |
|
Apr 6, 2026
9w ago
|
EFFECT
| $3.06 $3.03 | ▼ −0.98% | ▼ −1.04% | $2.91 (−4.90%) |
|
Apr 1, 2026
9w ago
|
EFFECT
| $3.09 $3.07 | ▼ −0.65% | ▼ −0.73% | $2.91 (−5.83%) |
|
Mar 30, 2026
10w ago
|
6-K
| $3.01 $3.10 | ▲ +2.99% | ▲ +0.10% | $2.91 (−3.32%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $3.01 $3.10 | ▲ +2.99% | ▲ +0.10% | $2.91 (−3.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access